EGFR and breast carcinoma: Among RTKs, the EGFR and the IGF-IR mediate signaling pathways that regulate the expression of target genes during breast cancer progression, thereby influencing cell proliferation, metabolic reprogramming, apoptotic evasion, EMT, invasion, and metastasis [19,20].